AMEDEI, AMEDEO
 Distribuzione geografica
Continente #
NA - Nord America 12.282
EU - Europa 9.983
AS - Asia 2.545
OC - Oceania 147
AF - Africa 74
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 3
Totale 25.080
Nazione #
US - Stati Uniti d'America 12.237
RU - Federazione Russa 3.188
PL - Polonia 3.093
IT - Italia 1.220
IE - Irlanda 929
HK - Hong Kong 849
SE - Svezia 662
SG - Singapore 647
CN - Cina 385
IN - India 209
FI - Finlandia 190
DE - Germania 168
UA - Ucraina 163
ID - Indonesia 153
AU - Australia 143
GB - Regno Unito 131
JO - Giordania 123
VN - Vietnam 94
NL - Olanda 66
CI - Costa d'Avorio 42
CH - Svizzera 37
FR - Francia 37
BR - Brasile 35
CA - Canada 33
TR - Turchia 30
BE - Belgio 23
ES - Italia 19
AT - Austria 14
EG - Egitto 12
KR - Corea 11
CZ - Repubblica Ceca 9
JP - Giappone 9
IL - Israele 8
MX - Messico 8
RO - Romania 8
SC - Seychelles 7
UG - Uganda 5
BG - Bulgaria 4
IR - Iran 4
LT - Lituania 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
ZA - Sudafrica 4
AR - Argentina 3
BD - Bangladesh 3
EU - Europa 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NP - Nepal 2
PT - Portogallo 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HU - Ungheria 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
Totale 25.080
Città #
Santa Clara 3.496
Warsaw 3.090
Fairfield 1.296
Dublin 920
Chandler 701
Ashburn 675
Woodbridge 565
Seattle 550
Cambridge 517
Singapore 512
Houston 500
Hong Kong 449
Wilmington 410
Altamura 314
Lawrence 309
Florence 274
Jacksonville 253
Ann Arbor 242
Princeton 224
Mumbai 160
Jakarta 153
Melbourne 138
Boston 136
Moscow 124
Beijing 115
Boardman 95
New York 90
Dong Ket 86
Medford 83
San Diego 81
Shanghai 77
Helsinki 53
Milan 50
Buffalo 45
Abidjan 42
Pune 37
Falls Church 36
Los Angeles 36
Rome 36
Kent 34
Hillsboro 33
London 32
West Jordan 28
Yubileyny 26
Toronto 24
Bern 22
Brussels 21
Norwalk 21
Phoenix 21
Lappeenranta 20
Redwood City 19
Fiesole 18
Council Bluffs 17
Izmir 17
Andover 16
Munich 16
Salerno 14
Dearborn 13
Guangzhou 13
Vienna 13
Auburn Hills 12
Barcelona 12
Castelliri 10
Nanjing 10
Central 9
Falkenstein 9
Bari 8
Frankfurt Am Main 8
Seoul 8
Washington 8
Cairo 7
Frankfurt am Main 7
Kilburn 7
Paris 7
Pisa 7
Romola 7
Sesto Fiorentino 7
Bologna 6
Chiswick 6
Hounslow 6
Indore 6
Shenzhen 6
Bagno a Ripoli 5
Brno 5
Cesena 5
Genoa 5
Kampala 5
Nuremberg 5
Palermo 5
Tokyo 5
Verona 5
Amandola 4
Bremen 4
Bucharest 4
Catania 4
Lucca 4
Menlo Park 4
Muralto 4
Naples 4
Ottawa 4
Totale 17.662
Nome #
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 320
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 299
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 296
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 270
Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration 265
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 261
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 258
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 255
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 238
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 232
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 228
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 222
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 221
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 218
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 218
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 208
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 200
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 187
Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine 181
T cells in gastric cancer: friends or foes. 177
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 169
Healthy axis: Towards an integrated view of the gut-brain health 169
I’ve gut a feeling: Microbiota impacting the conceptual and experimental perspectives of personalized medicine 169
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. 168
Evaluation and comparison of short chain fatty acids composition in gut diseases 166
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 165
Thrombosis in vasculitis: from pathogenesis to treatment 162
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 161
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 155
Effect of probiotics on oral candidiasis: A systematic review and meta-analysis 151
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 150
Gastric cancer and the epoch of immunotherapy approaches 150
The lung microbiome: clinical and therapeutic implications 149
The controversial role of Enterococcus faecalis in colorectal cancer 148
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 147
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy 141
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 140
Editorial of special issue “the interplay of microbiome and immune response in health and diseases” 140
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 134
Gut inflammatory diseases, infection, and nutrition 134
Role of Gut Microbiota-Immunity Axis in Patients Undergoing Surgery for Colorectal Cancer: Focus on Short and Long-Term Outcomes 134
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 132
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 132
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 131
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 130
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 129
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 129
Gut microbiota and artificial intelligence approaches: A scoping review 129
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. 128
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 128
The interplay between the microbiome and the adaptive immune response in cancer development 126
Designing a broad-spectrum integrative approach for cancer prevention and treatment 123
Moraxella catarrhalis-specific Th1 cells in BAL fluids of chronic obstructive pulmonary disease patients. 122
Targeting IL-23 in human diseases. 121
Usefulness of 13C-Urea Breath Test in the diagnosis of gastric Helicobacter pylori infection. 121
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 120
Immunosuppression of TH2 responses in Trichinella spiralis infection by Helicobacter pylori Neutrophil Activating Protein 119
Impact of acidosis on ζ-crystallin-mediated bcl-2 expression in leukemic cell lines 118
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 118
Novel immunotherapeutic strategies of gastric cancer treatment 117
Exploring the food-gut axis in immunotherapy response of cancer patients 117
Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients 117
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 116
Broad targeting of resistance to apoptosis in cancer 115
Effectiveness of a Khorasan Wheat–Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia 115
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 115
Preliminary Analysis of the Presence of Bacterial Azurin Coding Gene in CRC Patients and Correlation with the Microbiota Composition 114
In vitro expression of proalfa1 (I)collagen mRNA by human preosteoclastic cells 114
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. 114
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 114
Circulating metabolites originating from gut microbiota control endothelial cell function 113
The story so far: Helicobacter pylori and gastric autoimmunity. 112
Role of diet and gut microbiota on Colorectal cancer immunomodulation 112
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 112
In vivo relevance of CD30 in atopic dermatitis. 111
Helicobacter pylori and gastric autoimmunity. 111
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 111
Impaired TH2 response in patients with Vav1-deficient common variable immunodeficiency with T-cell defects. 110
New frontiers in cell-based immunotherapy of cancer. 109
Hydrogen sulfide effects on the survival of lactobacilli with emphasis on the development of inflammatory bowel diseases 109
Potential therapeutic strategies to target gut microbiota in hepatocellular carcinoma 108
Cancer Immunotherapy: The Share of Cytokines and Chemokines 107
Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma 105
STIMULATION OF TH 1 RESPONSE BY HELICOBACTER PYLORI NEUTROPHIL ACTIVATING PROTEIN DECREASES THE PROTECTIVE ROLE OF IgE AND EOSINOPHILS IN EXPERIMENTAL TRICHINELLOSIS 105
Helicobacter pylori, T cells and cytokines: the "dangerous liaisons". 105
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 105
Gastric autoimmunity: The role of Helicobacter pylori and molecular mimicry 104
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 104
Molecular specificity and functional properties of autoreactive T-cell response in human gastric autoimmunity. 103
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 102
Microparticles: Bridging the gap between autoimmunity and thrombosis 102
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 102
Cancer prevention and therapy through the modulation of the tumor microenvironment 102
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 102
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 102
Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects 101
T-cell response to bacterial agents 101
Helicobacter pylori, asthma and allergy. 101
Z-crystallin is a new stabilizing bcl-2 mRNA au-rich element binding protein overexpressed in the acute lymphocytic leukemia Jurkat T-CELL line 101
IFN-g-inducible protein (IP-10/CXCL)10 and pentraxin (PTX)3 plasma levels are tools for monitoring inflammation and disease activity in M. tuberculosis infection. 100
Totale 14.652
Categoria #
all - tutte 80.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.471 0 0 0 0 0 0 0 460 362 241 327 81
2020/20212.491 210 247 148 292 148 241 133 208 198 376 111 179
2021/20221.377 36 107 138 64 40 64 48 163 62 57 187 411
2022/20234.044 360 854 172 221 246 625 510 407 365 56 144 84
2023/20241.902 62 154 287 91 125 332 70 330 44 176 108 123
2024/20259.530 409 1.306 809 1.781 3.218 1.489 353 165 0 0 0 0
Totale 25.662